Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism · 2026-05 · 28 (5) · 3943-3954
DOI: 10.1111/dom.70576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 26.02.2026. Verfasst von Moses Yidong Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Preventive Medicine, Office of Clinical Epidemiology, Analytics, and Knowledge, Tan Tock Seng Hospital, Tan Tock Seng,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycated Hemoglobin, Diabetic Angiopathies. Die Arbeit nennt 47 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
We examined the association between visit‐to‐visit HbA1c variability and risk of mortality, acute myocardial infarction (AMI), stroke, lower extremity amputation (LEA), neuropathy, and nephropathy.
Methods
We conducted a retrospective cohort study of adults with type 2 diabetes managed at specialist outpatient clinics between 2009 and 2017. HbA1c variability was assessed using intra‐individual visit‐to‐visit coefficient of variation (COV), variation independent of mean (VIM), and HbA1c Variability Score (HVS). Diabetes‐related outcomes were identified using diagnosis and service codes. Cox proportional hazards and weighted Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
The cohort comprised 18 293 patients (mean age: 63.8 ± 13.1 years; 55.1% male). Compared to those in the lowest quartiles of HbA1c variability, patients in the highest quartile had higher HRs for mortality (COV: HR = 2.03, 95% CI: 1.43–2.88; VIM: HR = 2.70, 95% CI: 1.61–4.53; HVS: HR = 2.32, 95% CI: 1.49–3.62), and nephropathy (COV: HR = 1.34, 95% CI: 1.14–1.56; VIM: HR = 1.31, 95% CI: 1.14–1.52; HVS: HR = 1.20, 95% CI: 1.04–1.39), with statistically significant tests for linear trend. No significant associations were observed between HbA1c variability and AMI (HR = 0.88, 95% CI: 0.51–1.52), stroke (HR = 1.19, 95% CI: 0.92–1.56), neuropathy (HR = 1.01, 95% CI: 0.80–1.28), or LEA (HR = 1.00, 95% CI: 0.65–1.55).
Conclusion
Higher HbA1c variability was associated with significantly increased risk of mortality and nephropathy, but not significantly associated with the risk of AMI, stroke, neuropathy, or LEA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Preventive Medicine, Office of Clinical Epidemiology, Analytics, and Knowledge, Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Endocrinology, Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
ORCID-Profile: Moses Yidong Lim, Htet Lin Htun, Wei-Yen Lim
Zitieren
APA
Lim, M. Y., Lian, W., Phua, H. P., Htun, H. L., Chew, D. E. K., Quek, T. P. L., & Lim, W. Y. (2026). Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 28(5), 3943-3954. https://doi.org/10.1111/dom.70576
Vancouver
Lim MY, Lian W, Phua HP, Htun HL, Chew DEK, Quek TPL, et al. Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. 2026;28(5):3943-3954. doi:10.1111/dom.70576
BibTeX
@article{Lim2026,
author = {Lim, Moses Yidong and Lian, Weixiang and Phua, Hwee Pin and Htun, Htet Lin and Chew, Daniel Ek Kwang and Quek, Timothy Peng Lim and Lim, Wei-Yen},
title = {Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {5},
pages = {3943--3954},
doi = {10.1111/dom.70576}
}
EUVIMED